Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Development of newborn and infant vaccines.

Sanchez-Schmitz G, Levy O.

Sci Transl Med. 2011 Jul 6;3(90):90ps27. doi: 10.1126/scitranslmed.3001880.

2.

Towards Predicting Protective Vaccine Responses in the Very Young.

Kollmann TR, Marchant A.

Trends Immunol. 2016 Aug;37(8):523-34. doi: 10.1016/j.it.2016.05.005. Epub 2016 Jun 22. Review.

PMID:
27344245
3.

Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines.

Dauby N, Alonso-Vega C, Suarez E, Flores A, Hermann E, Córdova M, Tellez T, Torrico F, Truyens C, Carlier Y.

PLoS Negl Trop Dis. 2009 Dec 22;3(12):e571. doi: 10.1371/journal.pntd.0000571.

4.

Does antigenic overload exist? The role of multiple immunizations in infants.

Gregson AL, Edelman R.

Immunol Allergy Clin North Am. 2003 Nov;23(4):649-64. Review.

PMID:
14753385
5.

Vaccination of children--a systematic review.

Ortqvist Å, Blennow M, Carlsson RM, Hanson LÅ, Lindberg A, Lindqvist L, Magnusson M, Nilsson L, Norlund A, Nyrén O, Olcén P, Olin P, Silfverdal SA, Säwe J, Söderström A, Trollfors B.

Acta Paediatr. 2010 Sep;99(461):1-192. Review. No abstract available.

PMID:
20712829
6.

Immune response to vaccine adjuvants during the first year of life.

Levy O, Goriely S, Kollmann TR.

Vaccine. 2013 May 17;31(21):2500-5. doi: 10.1016/j.vaccine.2012.10.016. Epub 2012 Oct 18. Review.

7.

A small jab - a big effect: nonspecific immunomodulation by vaccines.

Benn CS, Netea MG, Selin LK, Aaby P.

Trends Immunol. 2013 Sep;34(9):431-9. doi: 10.1016/j.it.2013.04.004. Epub 2013 May 14. Review.

PMID:
23680130
8.

Age and the Immune System.

Ghia CJ, Naik M, Ved J, Rambhad G.

J Assoc Physicians India. 2015 Apr;63(4 Suppl):17-8. Review. No abstract available.

PMID:
26562958
9.

Developmental immunology and vaccines: cellular immune development and future vaccine strategies.

Prescott S.

Expert Rev Vaccines. 2004 Aug;3(4):339-42. Review.

PMID:
15270630
10.

Vaccination in the neonatal period and early infancy.

Siegrist CA.

Int Rev Immunol. 2000;19(2-3):195-219. Review.

PMID:
10763709
11.

T cell-mediated immune responses in human newborns: ready to learn?

Marchant A, Goldman M.

Clin Exp Immunol. 2005 Jul;141(1):10-8. Review.

12.

Human immune responses to vaccines in the first year of life: biological, socio-economic and ethical issues - a viewpoint.

Ota MO, Idoko OT, Ogundare EO, Afolabi MO.

Vaccine. 2013 May 17;31(21):2483-8. doi: 10.1016/j.vaccine.2012.06.018. Epub 2012 Jun 19. Review.

PMID:
22728219
13.

Epidemiological determinants of successful vaccine development.

Nishiura H, Mizumoto K.

Int J Med Sci. 2013;10(4):382-4. doi: 10.7150/ijms.5689. Epub 2013 Feb 21.

14.

Vaccines for travel and international adoption.

Lee PJ.

Pediatr Infect Dis J. 2008 Apr;27(4):351-4. doi: 10.1097/INF.0b013e31816f1368. Review.

PMID:
18379374
15.

Importance of vaccines in child survival.

Ramalingaswami V.

Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S498-502. Review.

PMID:
2669093
16.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.

Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.

Vaccine. 2003 Jul 28;21(24):3398-405. Review.

PMID:
12850348
17.

Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015.

Sobanjo-Ter Meulen A, Abramson J, Mason E, Rees H, Schwalbe N, Bergquist S, Klugman KP.

Vaccine. 2015 Nov 25;33(47):6388-95. doi: 10.1016/j.vaccine.2015.08.047. Epub 2015 Aug 24. Review.

18.

Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.

Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, Newport MJ, Aaby P, Whittle H, Lambert PH, McAdam KP, Siegrist CA, Marchant A.

J Immunol. 2002 Jan 15;168(2):919-25.

19.

Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines.

Siegrist CA, Lambert PH.

Springer Semin Immunopathol. 1997;19(2):233-43. Review. No abstract available.

PMID:
9406349
20.

Population biology, evolution, and immunology of vaccination and vaccination programs.

Halloran ME, Anderson RM, Azevedo-Neto RS, Bellini WJ, Branch O, Burke MA, Compans R, Day K, Gooding L, Gupta S, Katz J, Kew O, Keyserling H, Krause R, Lal AA, Massad E, McLean AR, Rosa P, Rota P, Wiener P, Wynn SG, Zanetta DM.

Am J Med Sci. 1998 Feb;315(2):76-86.

PMID:
9472906

Supplemental Content

Support Center